Skip to content

Clinical trials

Phase 4 Stroke trials in South Korea

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Stroke Phase: Phase 4 Country / region: South Korea Clear all

18 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20071
20081
20101
20112
20122
20142
20161
20181
20191
20211
20241
20252
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed7
Unknown status6
Recruiting4
Not yet recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Yonsei University4
Asan Medical Center2
Samsung Medical Center2
Boehringer Ingelheim1
Chonnam National University Hospital1
Hanmi Pharmaceutical Company Limited1
Jae-Kwan Song1
National Rehabilitation Center, Seoul, Korea1
Population Health Research Institute1
Samjin Pharmaceutical Co., Ltd.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Stroke18
Atrial Fibrillation2
Muscle Spasticity2
Arteriosclerosis1
Cerebral Infarction1
Cognitive Dysfunction1
Death1
Foramen Ovale, Patent1
Gait Disorders, Neurologic1
Gastrointestinal Hemorrhage1

Trials

Showing 1 to 18 of 18. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.